Hence, the bona fide LLPC which may be a subset of the CD19neg BM ASC population likely harbors Flu- and Tet-specificities as well as measles- and mumps-specificities but appears to exclude SARS2-specific responses. This evidence concerns the gene SARS2 and measles.